- Home
- TBI vs XFOR Comparison
TBI vs XFOR Comparison
Compare TBI & XFOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TBI | XFOR |
|---|---|---|
| Founded | 1985 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 311.4M | 288.5M |
| IPO Year | 1995 | 2017 |
Fundamental Metrics
Financial Performance| Metric | TBI | XFOR |
|---|---|---|
| Price | $12.60 | $3.25 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $14.25 | $11.60 |
| AVG Volume (30 Days) | 275.2K | ★ 639.9K |
| Earning Date | 11-04-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 61.39 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $6,500,000.00 |
| Revenue This Year | $11.59 | N/A |
| Revenue Next Year | $6.18 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 150.00 |
| 52 Week Low | $3.18 | $2.43 |
| 52 Week High | $13.59 | $4.83 |
Technical Indicators
Market Signals| Indicator | TBI | XFOR |
|---|---|---|
| Relative Strength Index (RSI) | 77.95 | 53.39 |
| Support Level | $6.48 | $3.19 |
| Resistance Level | N/A | $3.52 |
| Average True Range (ATR) | 0.69 | 0.24 |
| MACD | 0.37 | 0.02 |
| Stochastic Oscillator | 81.31 | 59.66 |
Price Performance
Historical ComparisonAbout TBI TrueBlue Inc.
TrueBlue Inc is a provider of specialized workforce solutions that connect employers with talent. Its reportable segments include PeopleReady, which provides blue-collar contingent staffing and delivers on-demand and skilled labor across industries such as construction, transportation, retail, hospitality, and energy. The PeopleManagement segment offers contingent labor and outsourced industrial workforce solutions, mainly on-site at client facilities, through its OnSite and Centerline operations, focusing on workforce management and commercial driver services. PeopleSolutions delivers services focused on professional and specialized talent acquisition, as well as workforce management and compliance. The company generates the majority of its revenue from the PeopleReady segment.
About XFOR X4 Pharmaceuticals Inc.
X4 Pharmaceuticals Inc is a biopharmaceutical company developing and commercializing novel therapeutics for the treatment of rare hematology diseases. The Company's clinical candidate is mavorixafor, a small molecule antagonist of the chemokine receptor CXCR4 that is being developed as an oral, once-daily therapy. It can increase the mobilization of mature, functional white blood cells from the bone marrow into the bloodstream. It also has two pre-clinical candidates X4P-003 and X4P-002 which are CXCR4 antagonists with different properties.